SCHEMBL4938573

SCHEMBL4938573

COC(=O)c1cccc(-c2nc3c(-c4ccc(C(N)=O)cc4)ccnc3[nH]2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHUK O15111 5/20 0.48
CAMKK2 Q96RR4 5/20 0.48
INSR P06213 4/20 0.48
MAPK8 P45983 4/20 0.48
PLAU P00749 1/20 0.46
PLAT P00750 1/20 0.46
PRKCI P41743 1/20 0.46
IKBKB O14920 1/20 0.46
ASH1L Q9NR48 1/20 0.44
KDM4E B2RXH2 2/20 0.44
ALDH1A1 P00352 2/20 0.44
CYP3A4 P08684 1/20 0.43
MAPK14 Q16539 1/20 0.43
PKN1 Q16512 1/20 0.43
PKN2 Q16513 1/20 0.43
CDK8 P49336 1/20 0.43
NEK1 Q96PY6 2/20 0.42
RIPK1 Q13546 1/20 0.42
NPC1 O15118 1/20 0.42
LMNA P02545 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4940389 0.89 NEK1 (0.45) PLAUPLATKDM4EALDH1A1CYP3A4
SCHEMBL4934472 0.89 PRKCI (0.48) CHUKCAMKK2INSRMAPK8PRKCI
SCHEMBL14027958 0.84 CHUK (0.57) CHUKCAMKK2INSRMAPK8PRKCI
Hydrochloric Acid SCHEMBL4938858 0.84 CHUK (0.56) CHUKCAMKK2INSRMAPK8PRKCI
SCHEMBL4934713 0.81 NEK1 (0.48) KDM4EALDH1A1MAPK14NEK1NPC1
SCHEMBL4937700 0.81 CDK8 (0.47) KDM4EALDH1A1MAPK14PKN1PKN2
SCHEMBL1838448 0.81 MKNK2 (0.58) CHUKCAMKK2INSRMAPK8PRKCI
SCHEMBL4933913 0.80 RAB9A (0.47) KDM4EALDH1A1MAPK14NPC1PKM
SCHEMBL14027963 0.80 RIPK1 (0.49) CHUKCAMKK2INSRMAPK8CYP3A4
Hydrochloric Acid SCHEMBL4940884 0.80 RIPK1 (0.48) CHUKCAMKK2INSRMAPK8CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080255085-A1 Novel Imidazo [4,5-b] Pyridine Derivatives as Inhibitors of Glycogen Synthase Kinase 3 for Use in the Treatment of Dementia and Neurodegenerative Disorders ASTRAZENECA AB (SE) 2008-10-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255085-A1 Novel Imidazo [4,5-b] Pyridine Derivatives as Inhibitors of Glycogen Synthase Kinase 3 for Use in the Treatment of Dementia and Neurodegenerative Disorders GSK3B, GSK3A, PYGB CHUK 90/4885CAMKK2 201/4885INSR 369/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.